North America is expected to remain a leading region in the global atrial fibrillation market through 2034, supported by a mature healthcare infrastructure, a growing aging population, high awareness of cardiovascular diseases, and the rapid adoption of advanced cardiac technologies. The region dominated the market in 2025, according to The Insight Partners. Increasing demand for minimally...